Michael Tansey, MD
Clinical Professor of Pediatrics, Stead Family Department of Pediatrics at the University of Iowa
Douglas Vanderbilt, MD, MS
Director of the Developmental-Behavioral Pediatrics, Associate Professor, Children’s Hospital Los Angeles, University of Southern California
John V. Williams, MD
Professor of Pediatrics, Chief, Division of Infectious Diseases, Institute for Infection, Inflammation, and Immunity in Children
Dr. Michael Tansey is a Clinical Professor of Pediatrics in the Stead Family Department of Pediatrics at the University of Iowa. He received his B.S. in Biology from Creighton University and his M.D. from Loyola Stritch School of Medicine. He completed a pediatric residency and pediatric endocrinology fellowship at the University of Iowa Hospitals and Clinics. His career has focused on clinical studies of children with type 1 diabetes. He started his research career in 2001 as an investigator in the Diabetes in Research Children Network (DirecNet) and has continued to work with this innovative and productive research group. Dr. Tansey has also been engaged with other major clinical trials in children with type 1 diabetes including the JDRF Artificial Pancreas Project examining the role of continuous glucose monitoring in type1 diabetes and the T1D Exchange Study. He has also made important contributions to the body of literature in the area of exercise and glycemic effects in type 1 diabetes.
Michael Tansey, MD
Clinical Professor of Pediatrics, Stead Family Department of Pediatrics at the University of Iowa
Dr. Douglas Vanderbilt is the Director of the Developmental-Behavioral Pediatrics (DBP) Section at Children’s Hospital Los Angeles (CHLA) and an Associate Professor of Clinical Pediatrics at Keck School of Medicine and Occupational Science/Occupational Therapy at University of Southern California USC. He completed his medical school at the University of Tennessee, residency at UCLA, and DBP fellowship and a 2-year faculty appointment at Boston University. At USC and CHLA, he attained a KL2 Mentored Career Development Award to study the outcomes of High-Risk Infants (HRI) and has contributed to over 70 manuscripts, policy statements, editorials, and chapters. He also obtained several federal MCHB training grants for the California Leadership Education in Neurodevelopmental Disabilities and DBP training programs and been a Co-I on several NIH grants. As ACGME DBP fellowship director, he has graduated 9 DBP fellows and is partnering across the pediatric residency programs of the Los Angeles basin at Los Angeles County + USC, UCI-CHOC, Kaiser, and UCLA for DBP training. As the medical director of the HRI follow-up clinic at CHLA, he has led the effort to bring an interdisciplinary team of nutrition, nursing, occupational and physical therapy, psychology, and social work staff together to enhance the parent-infant relationship of NICU gradutates. He is an Associate Director of the USC University Center for Excellence in Developmental Disabilities for his work on the CA-LEND program. Dr. Vanderbilt serves as a member of the subboard for DBP with the American Board of Pediatrics. He is an executive committee member for the Council on Early Childhood with the AAP and permanent member of the NICHD Biobehavioral and Behavioral Sciences (CHHD-H) Study Section.
Douglas Vanderbilt, MD, MS
Director of the Developmental-Behavioral Pediatrics, Associate Professor, Children’s Hospital Los Angeles, University of Southern California
John V. Williams, MD, is Henry L. Hillman Professor of Pediatric Immunology; Chief, Division of Infectious Diseases; and Director, Institute for Infection, Inflammation, and Immunity in Children (i4Kids). Dr. Williams is an international authority on the epidemiology, immunity, and pathogenesis of respiratory viruses. The major focus of his research is the immunity and pathogenesis of human metapneumovirus (HMPV). His team described the epidemiology of HMPV, a leading cause of lower respiratory infection. His lab discovered that HMPV uses integrins as receptors to enter cells through endocytosis. His group identified the HMPV F protein as a protective antigen and showed that F protein was an effective vaccine. Dr. Williams’ lab discovered that HMPV and other acute respiratory viruses induce lung CD8+ T cell impairment via the PD-1 signaling pathway, previously associated with chronic infections and cancer, and that this impairment limits memory and vaccine responses to respiratory viruses.
Dr. Williams also leads CDC-funded surveillance studies of acute respiratory and gastrointestinal infections in children based at Children’s Hospital of Pittsburgh, one of only seven sites nationally. He conducts collaborative research with clinical investigators at the University of Pittsburgh and international sites. He has participated in studies of respiratory virus epidemiology in North America, South America, the Middle East, and Africa. His group has published studies on coronaviruses, influenza virus, HMPV, parainfluenza viruses, respiratory syncytial virus, and rhinoviruses in diverse populations.
He completed his undergraduate education at Northern Virginia Community College and the University of Virginia and attended medical school at the Medical College of Virginia/Virginia Commonwealth University. He trained in pediatrics at Children’s Hospital of Pittsburgh/University of Pittsburgh and completed fellowship in Pediatric Infectious Diseases at Vanderbilt University Medical Center.
He has authored or co-authored more than 150 original articles, reviews, and chapters about his research, which has been supported by grants from the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC). Dr. Williams is a member of the editorial boards of the Journal of Virology and Journal of the Pediatric Infectious Disease Society. He has been an active mentor of graduate and medical students, residents, and fellows, and is a standing member of the NIH/NIAID MID-B Study Section. He has been recognized for his teaching and research accomplishments with the Society for Pediatric Research E. Mead Johnson Award, the Mary Ann and John Hash Award for Outstanding Teaching of Graduate Students in Microbiology and Immunology, and the inaugural Caroline B. Hall Award for Translational Research from the Pediatric Infectious Diseases Society.
John V. Williams, MD
Professor of Pediatrics, Chief, Division of Infectious Diseases, Institute for Infection, Inflammation, and Immunity in Children